All Comments by Hiroshi Mori

  1. Apolipoprotein E polymorphism in elderly east Africans.
  2. Slow degradation of aggregates of the Alzheimer's disease amyloid beta-protein by microglial cells.
  3. Analysis of the butyrylcholinesterase gene and nearby chromosome 3 markers in Alzheimer disease.
  4. Appearance of sodium dodecyl sulfate-stable amyloid beta-protein (Abeta) dimer in the cortex during aging.
  5. Transgenic expression of the shortest human tau affects its compartmentalization and its phosphorylation as in the pretangle stage of Alzheimer's disease.
  6. Astrocytes containing amyloid beta-protein (Abeta)-positive granules are associated with Abeta40-positive diffuse plaques in the aged human brain.
  7. Assembled tau filaments differ from native paired helical filaments as determined by scanning transmission electron microscopy (STEM).
  8. Increased frequency of the alpha-1-antichymotrypsin T allele in cerebral amyloid angiopathy.
  9. No association of presenilin-1 intronic polymorphism and Alzheimer's disease in Australia.
  10. E2F1 mediates death of B-amyloid-treated cortical neurons in a manner independent of p53 and dependent on Bax and caspase 3.
  11. A presenilin-1-dependent gamma-secretase-like protease mediates release of Notch intracellular domain.
  12. ApoE genotype is a risk factor in nonpresenilin early-onset Alzheimer's disease families.
  13. Oxidative metabolism in cultured fibroblasts derived from sporadic Alzheimer's disease (AD) patients.
  14. Cerebrovascular accumulation and increased blood-brain barrier permeability to circulating Alzheimer's amyloid beta peptide in aged squirrel monkey with cerebral amyloid angiopathy.
  15. Apolipoprotein E and Tau phosphorylation in human neuroblastoma cells.